Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability,... Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. Mostrar mais
Pergunte à ADVFN Intelligence (IA)
| Período | Var | Var % | Abe | Máx. | Mín. | Vol Méd. | VWAP diário | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.02 | -0.573065902579 | 3.49 | 3.61 | 3.27 | 73250 | 3.4187829 | CS |
| 4 | 0.44 | 14.5214521452 | 3.03 | 3.72 | 2.71 | 101197 | 3.23916172 | CS |
| 12 | 0.29 | 9.11949685535 | 3.18 | 4.29 | 2.71 | 107029 | 3.37811441 | CS |
| 26 | -1.13 | -24.5652173913 | 4.6 | 4.88 | 2.71 | 177828 | 3.57314288 | CS |
| 52 | -8.96 | -72.0836685438 | 12.43 | 12.81 | 2.71 | 221714 | 4.86281486 | CS |
| 156 | -23.96 | -87.3496172074 | 27.43 | 28.245 | 2.71 | 237961 | 11.29498195 | CS |
| 260 | -28.58 | -89.1731669267 | 32.05 | 46.44 | 2.71 | 206757 | 15.25155741 | CS |
Parece que você não está logado. Clique no botão abaixo para se logar e ver seu histórico recente.
Suporte: (11) 4950 5808 | suporte@advfn.com.br
Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições
Recursos principais
Premium
